Skip to main content
SpringerLink
Log in

Fungal Infections

  • Chapter
  • First Online:
Skin Disorders in Migrants

  • 312 Accesses

Abstract

Fungal infections, or mycoses, affecting the skin can present in migrant populations, and as the organisms and their clinical features may be different and unfamiliar, it is useful to consider this group of infections separately. The presentation and distribution of mycoses can also be affected by a number of other factors including the presence of the organisms in the environment, immunity of the host, the route of exposure, and the presence of any underlying disease as well as the use of immunosuppressive medical treatment.

Mycoses are traditionally divided into the superficial, which mainly affect the skin or mucous membranes, and deep, which affect deeper structure and internal organs. These deep infections are also further subdivided into those that mainly affect the deep dermis and subcutaneous tissues (the subcutaneous mycoses) and those that can affect any internal organ as well as the skin and may spread through the bloodstream to multiple sites (the systemic mycoses). The latter are potentially fatal if untreated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. The University of Adelaide. http://www.mycology.adelaide.edu.au/Mycoses/Cutaneous/Dermatophytosis.

  2. Dhaille F, Dillies AS, Dessirier F, et al. A single typical trichoscopic feature is predictive of tinea capitis: a prospective multicenter study. Br J Dermatol. 2019;181:1046–51. https://doi.org/10.1111/bjd.17866.

    Article  CAS  PubMed  Google Scholar 

  3. Zander N, Sommer R, Schäfer I, et al. Epidemiology and dermatological comorbidity of seborrhoeic dermatitis: population-based study in 161,000 employees. Br J Dermatol. 2019;181:743–8. https://doi.org/10.1111/bjd.17826.

    Article  CAS  PubMed  Google Scholar 

  4. Jha B, Bhattarai S, Sapkota J, et al. Dermatophytes in skin, nail and hair among the patients attending out patient department. J Nepal Health Res Counc. 2019;16(41):434–7.

    PubMed  Google Scholar 

  5. Singh S, Verma P, Chandra U, Tiwary NK. Risk factors for chronic and chronic-relapsing tinea corporis, tinea cruris and tinea faciei: results of a case-control study. Indian J Dermatol Venereol Leprol. 2019;85(2):197–200. https://doi.org/10.4103/ijdvl.IJDVL_807_17.

    Article  PubMed  Google Scholar 

  6. Burlina PM, Joshi NJ, Ng E, et al. Automated detection of erythema migrans and other confounding skin lesions via deep learning. Comput Biol Med. 2019;105:151–6. https://doi.org/10.1016/j.compbiomed.2018.12.007.

    Article  PubMed  Google Scholar 

  7. May PJ, Tong SYC, Steer AC, et al. Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review. Trop Med Int Health. 2019;24(3):280–93. https://doi.org/10.1111/tmi.13198.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ameen M. Epidemiology of superficial fungal infections. Clin Dermatol. 2010;28:197–201.

    Article  Google Scholar 

  9. Hogewoning AA, Adegnika AA, Bouwes Bavinck JN, et al. Prevalence and causative fungal species of tinea capitis among schoolchildren in Gabon. Mycoses. 2011;54:354–9.

    Article  Google Scholar 

  10. Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol. 2000;42:1–20.

    Article  CAS  Google Scholar 

  11. HPA Publications. Tinea capitis in the United Kingdom: a report on its diagnosis, management and prevention; 2008. http://www.hpa.org.uk/webc/hpawebfile/hpaweb_c/1194947321499.

  12. Howell SA, Clayton YM, Phan QG, Noble WC. Tinea pedis: the relationship between symptoms and host characteristics. Microbiol Ecol Health & Dis. 1988;1:131–8.

    Article  Google Scholar 

  13. Rotta I, Ziegelmann PK, Otuki MF, et al. Efficacy of topical antifungals in the treatment of dermatophytosis: a mixed-treatment comparison meta-analysis involving 14 treatments. JAMA Dermatol. 2013;149:341–9.

    Article  CAS  Google Scholar 

  14. Gupta AK, Simpson FC. New therapeutic options for onychomycosis. Expert Opin Pharmacother. 2012;13:1131–42.

    Article  CAS  Google Scholar 

  15. Gupta AK, Mays RR, Versteeg SG, et al. Update on current approaches to diagnosis and treatment of onychomycosis. Expert Rev Anti Infect Ther. 2018;16(12):929–38. https://doi.org/10.1080/14787210.2018.1544891.

    Article  CAS  PubMed  Google Scholar 

  16. Dei-Cas I, Carrizo D, Giri M, et al. Infectious skin disorders encountered in a pediatric emergency department of a tertiary care hospital in Argentina: a descriptive study. Int J Dermatol. 2019;58(3):288–95. https://doi.org/10.1111/ijd.14234.

    Article  PubMed  Google Scholar 

  17. Hay R. Therapy of skin, hair and nail fungal infections. J Fungi (Basel). 2018;4(3):pii: E99. https://doi.org/10.3390/jof4030099.

    Article  CAS  Google Scholar 

  18. Cassone A, Cauda R. Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders. AIDS. 2012;26:1457–72.

    Article  CAS  Google Scholar 

  19. Yano J, Sobel JD, Nyirjesy P, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health. 2019;19(1):48. https://doi.org/10.1186/s12905-019-0748-8.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Agarwal HS, Kuttesch JF. Candida albicans induced acute chest syndrome in sickle cell disease. Pediatr Blood Cancer. 2019;66:e27727. https://doi.org/10.1002/pbc.27727.

    Article  PubMed  Google Scholar 

  21. Öncü B, Belet N, Emecen AN, Birinci A. Health care-associated invasive Candida infections in children. Med Mycol. 2019;57:929–36. https://doi.org/10.1093/mmy/myz005.

    Article  PubMed  Google Scholar 

  22. Pfaller MA, Diekema DJ, Turnidge JD, et al. Twenty years of the SENTRY antifungal surveillance program: results for candida species from 1997-2016. Open Forum Infect Dis. 2019;6(Suppl 1):S79–94. https://doi.org/10.1093/ofid/ofy358.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Vieira de Melo AP, Zuza-Alves DL, da Silva-Rocha WP, et al. Virulence factors of Candida spp. obtained from blood cultures of patients with candidemia attended at tertiary hospitals in Northeast Brazil. J Mycol Med. 2019;29:132–9. https://doi.org/10.1016/j.mycmed.2019.02.002.

    Article  CAS  PubMed  Google Scholar 

  24. Prasad R, Nair R, Banerjee A. Emerging mechanisms of drug resistance in Candida albicans. Prog Mol Subcell Biol. 2019;58:135–53. https://doi.org/10.1007/978-3-030-13035-0_6.

    Article  CAS  PubMed  Google Scholar 

  25. Schlager E, Ashack K, Khachemoune A. Erosiointerdigitalis blastomycetica: a review of interdigital candidiasis. Dermatol Online J. 2018;24(8):pii:13030/qt8tm443f6.

    Google Scholar 

  26. Choi FD, Juhasz MLW, Atanaskova Mesinkovska N. Topical ketoconazole: a systematic review of current dermatological applications and future developments. J Dermatolog Treat. 2019;22:1–12. https://doi.org/10.1080/09546634.2019.1573309.

    Article  CAS  Google Scholar 

  27. Khongkunthian P, Grote M, Isaratanan W. Oral manifestations in 45 HIV-positive children from Northern Thailand. J Oral Pathol Med. 2001;30:549–52.

    Article  CAS  Google Scholar 

  28. Crespo Erchiga V, Delgado Florencio V. Malassezia species in skin diseases. Curr Opin Infect Dis. 2002;15:133–42.

    Article  Google Scholar 

  29. Fahal A, Mahgoub el S, El Hassan AM, Abdel-Rahman ME. Mycetoma in the Sudan: an update from the Mycetoma Research Centre, University of Khartoum, Sudan. PLoS Negl Trop Dis. 2015;9:e0003679.

    Article  Google Scholar 

  30. Gismalla MDA, Ahmed GMA, Mohamed Ali MM, et al. Surgical management of eumycetoma: experience from Gezira Mycetoma Center, Sudan. Trop Med Health. 2019;47:6. https://doi.org/10.1186/s41182-018-0129-2.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Guerra-Leal JD, Medrano-Danés LA, Montemayor-Martinez A, et al. The importance of diagnostic imaging of mycetoma in the foot. Int J Dermatol. 2018;58:600–4. https://doi.org/10.1111/ijd.14351.

    Article  CAS  PubMed  Google Scholar 

  32. Abbas M, Scolding PS, Yosif AA, et al. The disabling consequences of Mycetoma. PLoS Negl Trop Dis. 2018;12(12):e0007019. https://doi.org/10.1371/journal.pntd.0007019.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Yotsu RR. Integrated management of skin NTDs-lessons learned from existing practice and field research. Trop Med Infect Dis. 2018;3(4):pii:E120. https://doi.org/10.3390/tropicalmed3040120.

    Article  Google Scholar 

  34. Fahal AH, Suliman SH, Hay R. Mycetoma: the spectrum of clinical presentation. Trop Med Infect Dis. 2018;3(3):pii: E97. https://doi.org/10.3390/tropicalmed3030097.

    Article  Google Scholar 

  35. Fitzpatrick C, Nwankwo U, Lenk E, et al. An investment case for ending neglected tropical diseases. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major infectious diseases. 3rd ed. Washington, DC: The International Bank for Reconstruction and Development/The World Bank; 2017. Chapter 17.

    Google Scholar 

  36. Emmanuel P, Dumre SP, John S, et al. Mycetoma: a clinical dilemma in resource limited settings. Ann Clin Microbiol Antimicrob. 2018;17(1):35. https://doi.org/10.1186/s12941-018-0287-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Vora RV, Diwan NG, Singhal RR. Cutaneous tuberculosis mimicking a mycetoma. J Postgrad Med. 2018;64(3):174–6. https://doi.org/10.4103/jpgm.JPGM_710_16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Verma P, Jha A. Mycetoma: reviewing a neglected disease. Clin Exp Dermatol. 2019;44(2):123–9. https://doi.org/10.1111/ced.13642.

    Article  CAS  PubMed  Google Scholar 

  39. Bakhiet SM, Fahal AH, Musa AM, et al. A holistic approach to the mycetoma management. PLoS Negl Trop Dis. 2018;12(5):e0006391. https://doi.org/10.1371/journal.pntd.0006391.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Nazzaro G, Veraldi S. Mycetomas: the experience of the dermatology unit of the University of Milan. Dermatopathology (Basel). 2018;5(1):6–9. https://doi.org/10.1159/000486236.

    Article  Google Scholar 

  41. Correia RT, Valente NY, Criado PR, Martins JE. Chromoblastomycosis: study of 27 cases and review of medical literature. An Bras Dermatol. 2010;85:448–54.

    Article  Google Scholar 

  42. López-Romero E, Reyes-Montes Mdel R, Pérez-Torres A, et al. Sporothrixschenckii complex and sporotrichosis, an emerging health problem. Future Microbiol. 2011;6:85–102.

    Article  Google Scholar 

  43. Smith JA, Riddell J 4th, Kauffman CA. Cutaneous manifestations of endemic mycoses. Curr Infect Dis Rep. 2013;15:440–9.

    Article  Google Scholar 

  44. Ramos-e-Silva M, Lima CM, Schechtman RC, et al. Systemic mycoses in immunodepressed patients (AIDS). Clin Dermatol. 2012;30:616–27.

    Article  Google Scholar 

  45. Moreno-Coutiño G, Hernández-Castro R, Toussaint-Caire S, et al. Histoplasmosis and skin lesions in HIV: a safe and accurate diagnosis. Mycoses. 2015;58:413–5.

    Article  Google Scholar 

  46. Thomas I, Schwartz RA. Cutaneous manifestations of systemic cryptococcosis in immunosupressed patients. J Med. 2001;32:259–66.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. International Foundation for Dermatology, London, UK

    Roderick Hay

Authors
  1. Roderick Hay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roderick Hay .

Editor information

Editors and Affiliations

  1. San Gallicano Dermatological Institute IRCCS IFO, Rome, Italy

    Aldo Morrone

  2. International Foundation for Dermatology, London, UK

    Roderick Hay

  3. Foundation Global Dermatology, Munnekeburen, Friesland, The Netherlands

    Bernard Naafs

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hay, R. (2020). Fungal Infections. In: Morrone, A., Hay, R., Naafs, B. (eds) Skin Disorders in Migrants. Springer, Cham. https://doi.org/10.1007/978-3-030-37476-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-37476-1_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-37475-4

  • Online ISBN: 978-3-030-37476-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation